ID   OPT_HUMAN               Reviewed;         332 AA.
AC   Q9UBM4; Q5T2G4;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   07-APR-2021, entry version 169.
DE   RecName: Full=Opticin;
DE   AltName: Full=Oculoglycan;
DE   Flags: Precursor;
GN   Name=OPTC; Synonyms=OPT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=10636917; DOI=10.1074/jbc.275.3.2123;
RA   Reardon A.J., Le Goff M., Briggs M.D., McLeod D., Sheehan J.K.,
RA   Thornton D.J., Bishop P.N.;
RT   "Identification in vitreous and molecular cloning of opticin, a novel
RT   member of the family of leucine-rich repeat proteins of the extracellular
RT   matrix.";
RL   J. Biol. Chem. 275:2123-2129(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=10837509;
RA   Hobby P., Wyatt M.K., Gan W., Bernstein S., Tomarev S., Slingsby C.,
RA   Wistow G.J.;
RT   "Cloning, modeling, and chromosomal localization for a small leucine-rich
RT   repeat proteoglycan (SLRP) family member expressed in human eye.";
RL   Mol. Vis. 6:72-78(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10892843;
RA   Friedman J.S., Ducharme R., Raymond V., Walter M.A.;
RT   "Isolation of a novel iris-specific and leucine-rich repeat protein
RT   (oculoglycan) using differential selection.";
RL   Invest. Ophthalmol. Vis. Sci. 41:2059-2066(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS THR-182; CYS-229 AND TRP-325, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=12019215; DOI=10.1093/hmg/11.11.1333;
RA   Friedman J.S., Faucher M., Hiscott P., Biron V.L., Malenfant M.,
RA   Turcotte P., Raymond V., Walter M.A.;
RT   "Protein localization in the human eye and genetic screen of opticin.";
RL   Hum. Mol. Genet. 11:1333-1342(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-312.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18164633; DOI=10.1016/j.joca.2007.11.007;
RA   Monfort J., Tardif G., Roughley P., Reboul P., Boileau C., Bishop P.N.,
RA   Pelletier J.P., Martel-Pelletier J.;
RT   "Identification of opticin, a member of the small leucine-rich repeat
RT   proteoglycan family, in human articular tissues: a novel target for MMP-13
RT   in osteoarthritis.";
RL   Osteoarthritis Cartilage 16:749-755(2008).
RN   [10]
RP   TISSUE SPECIFICITY, AND CLEAVAGE BY MMP1; MMP2; MMP3; MMP7; MMP8; MMP9;
RP   ADAMTS4 AND ADAMTS5.
RX   PubMed=23845380; DOI=10.1016/j.jbspin.2013.05.007;
RA   Tio L., Martel-Pelletier J., Pelletier J.P., Bishop P.N., Roughley P.,
RA   Farran A., Benito P., Monfort J.;
RT   "Characterization of opticin digestion by proteases involved in
RT   osteoarthritis development.";
RL   Joint Bone Spine 81:137-141(2014).
RN   [11]
RP   SULFATION, AND TISSUE SPECIFICITY.
RX   PubMed=25136834; DOI=10.1371/journal.pone.0105409;
RA   Kanan Y., Siefert J.C., Kinter M., Al-Ubaidi M.R.;
RT   "Complement factor H, vitronectin, and opticin are tyrosine-sulfated
RT   proteins of the retinal pigment epithelium.";
RL   PLoS ONE 9:E105409-E105409(2014).
CC   -!- FUNCTION: Inhibits angiogenesis in the vitreous humor of the eye, and
CC       therefore represses neovascularization (By similarity). Binds collagen
CC       fibrils (By similarity). May be involved in collagen fiber organization
CC       via regulation of other members of the small leucine-rich repeat
CC       proteoglycan superfamily (By similarity).
CC       {ECO:0000250|UniProtKB:P58874, ECO:0000250|UniProtKB:Q920A0}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P58874}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:18164633}.
CC   -!- TISSUE SPECIFICITY: Expressed in cartilage and synovial membranes (at
CC       protein level) (PubMed:18164633, PubMed:23845380). Expressed in the
CC       retina, iris, ligament, skin and fetal liver (at protein level)
CC       (PubMed:12019215, PubMed:25136834). Expressed in the retinal pigment
CC       epithelium (at protein level) (PubMed:25136834). Expressed in synovial
CC       fibroblasts and subchondral bone osteoblasts (PubMed:18164633).
CC       {ECO:0000269|PubMed:12019215, ECO:0000269|PubMed:18164633,
CC       ECO:0000269|PubMed:23845380, ECO:0000269|PubMed:25136834}.
CC   -!- PTM: O-glycosylated. {ECO:0000305|PubMed:16335952}.
CC   -!- PTM: Proteolytically cleaved by MMP1, MMP2, MMP3, MMP7, MMP8, MMP9,
CC       ADAMTS4, and ADAMTS5 (PubMed:23845380). Proteolytically cleaved by
CC       MMP13 (By similarity). The degradation of OPTC by proteases may
CC       contribute to osteoarthritis pathophysiology (PubMed:23845380).
CC       {ECO:0000250|UniProtKB:P58874, ECO:0000269|PubMed:23845380}.
CC   -!- PTM: Sulfated on tyrosine residues. {ECO:0000269|PubMed:25136834}.
CC   -!- SIMILARITY: Belongs to the small leucine-rich proteoglycan (SLRP)
CC       family. SLRP class III subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ133790; CAB53459.1; -; mRNA.
DR   EMBL; AF161702; AAD45900.1; -; mRNA.
DR   EMBL; AY077681; AAL78286.1; -; mRNA.
DR   EMBL; AL391817; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW91482.1; -; Genomic_DNA.
DR   EMBL; BC074942; AAH74942.1; -; mRNA.
DR   EMBL; BC074943; AAH74943.1; -; mRNA.
DR   CCDS; CCDS1439.1; -.
DR   RefSeq; NP_055174.1; NM_014359.3.
DR   RefSeq; XP_011507708.1; XM_011509406.2.
DR   IntAct; Q9UBM4; 1.
DR   STRING; 9606.ENSP00000356191; -.
DR   GlyGen; Q9UBM4; 1 site.
DR   iPTMnet; Q9UBM4; -.
DR   PhosphoSitePlus; Q9UBM4; -.
DR   BioMuta; OPTC; -.
DR   DMDM; 8928250; -.
DR   MassIVE; Q9UBM4; -.
DR   PaxDb; Q9UBM4; -.
DR   PeptideAtlas; Q9UBM4; -.
DR   PRIDE; Q9UBM4; -.
DR   ProteomicsDB; 84008; -.
DR   Antibodypedia; 34546; 108 antibodies.
DR   Ensembl; ENST00000367222; ENSP00000356191; ENSG00000188770.
DR   GeneID; 26254; -.
DR   KEGG; hsa:26254; -.
DR   UCSC; uc001gzu.2; human.
DR   CTD; 26254; -.
DR   DisGeNET; 26254; -.
DR   GeneCards; OPTC; -.
DR   HGNC; HGNC:8158; OPTC.
DR   HPA; ENSG00000188770; Tissue enriched (retina).
DR   MIM; 605127; gene.
DR   neXtProt; NX_Q9UBM4; -.
DR   OpenTargets; ENSG00000188770; -.
DR   PharmGKB; PA31947; -.
DR   VEuPathDB; HostDB:ENSG00000188770.9; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   GeneTree; ENSGT00940000154248; -.
DR   HOGENOM; CLU_067583_2_0_1; -.
DR   InParanoid; Q9UBM4; -.
DR   OMA; NMIETMQ; -.
DR   OrthoDB; 914775at2759; -.
DR   PhylomeDB; Q9UBM4; -.
DR   TreeFam; TF351924; -.
DR   PathwayCommons; Q9UBM4; -.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   BioGRID-ORCS; 26254; 6 hits in 979 CRISPR screens.
DR   GeneWiki; Opticin; -.
DR   GenomeRNAi; 26254; -.
DR   Pharos; Q9UBM4; Tbio.
DR   PRO; PR:Q9UBM4; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9UBM4; protein.
DR   Bgee; ENSG00000188770; Expressed in placenta and 75 other tissues.
DR   ExpressionAtlas; Q9UBM4; baseline and differential.
DR   Genevisible; Q9UBM4; HS.
DR   GO; GO:0031012; C:extracellular matrix; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc.
DR   GO; GO:0030199; P:collagen fibril organization; ISS:UniProtKB.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   Pfam; PF13855; LRR_8; 1.
DR   SMART; SM00369; LRR_TYP; 4.
DR   PROSITE; PS51450; LRR; 4.
PE   1: Evidence at protein level;
KW   Disulfide bond; Extracellular matrix; Glycoprotein; Leucine-rich repeat;
KW   Reference proteome; Repeat; Secreted; Signal; Sulfation.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000250"
FT   CHAIN           20..332
FT                   /note="Opticin"
FT                   /id="PRO_0000032765"
FT   DOMAIN          116..153
FT                   /note="LRRNT"
FT   REPEAT          154..175
FT                   /note="LRR 1"
FT   REPEAT          178..199
FT                   /note="LRR 2"
FT   REPEAT          202..223
FT                   /note="LRR 3"
FT   REPEAT          248..269
FT                   /note="LRR 4"
FT   REPEAT          270..290
FT                   /note="LRR 5"
FT   REPEAT          300..320
FT                   /note="LRR 6"
FT   COMPBIAS        81..112
FT                   /note="Ser/Thr-rich"
FT   COMPBIAS        128..140
FT                   /note="Cys-rich"
FT   SITE            20..21
FT                   /note="Cleavage; by MMP7"
FT                   /evidence="ECO:0000269|PubMed:23845380"
FT   SITE            32..33
FT                   /note="Cleavage; by MMP7"
FT                   /evidence="ECO:0000269|PubMed:23845380"
FT   SITE            87..88
FT                   /note="Cleavage; by MMP2"
FT                   /evidence="ECO:0000269|PubMed:23845380"
FT   SITE            114..115
FT                   /note="Cleavage; by MMP13"
FT                   /evidence="ECO:0000250|UniProtKB:P58874"
FT   MOD_RES         65
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         71
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         139
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        312
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   DISULFID        289..322
FT                   /evidence="ECO:0000250"
FT   VARIANT         182
FT                   /note="I -> T (in dbSNP:rs139024490)"
FT                   /evidence="ECO:0000269|PubMed:12019215"
FT                   /id="VAR_055228"
FT   VARIANT         229
FT                   /note="R -> C (in dbSNP:rs150633473)"
FT                   /evidence="ECO:0000269|PubMed:12019215"
FT                   /id="VAR_055229"
FT   VARIANT         325
FT                   /note="R -> W (in dbSNP:rs56219555)"
FT                   /evidence="ECO:0000269|PubMed:12019215"
FT                   /id="VAR_055230"
SQ   SEQUENCE   332 AA;  37261 MW;  8060B4C46DF41C20 CRC64;
     MRLLAFLSLL ALVLQETGTA SLPRKERKRR EEQMPREGDS FEVLPLRNDV LNPDNYGEVI
     DLSNYEELTD YGDQLPEVKV TSLAPATSIS PAKSTTAPGT PSSNPTMTRP TTAGLLLSSQ
     PNHGLPTCLV CVCLGSSVYC DDIDLEDIPP LPRRTAYLYA RFNRISRIRA EDFKGLTKLK
     RIDLSNNLIS SIDNDAFRLL HALQDLILPE NQLEALPVLP SGIEFLDVRL NRLQSSGIQP
     AAFRAMEKLQ FLYLSDNLLD SIPGPLPLSL RSVHLQNNLI ETMQRDVFCD PEEHKHTRRQ
     LEDIRLDGNP INLSLFPSAY FCLPRLPIGR FT
//
